Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia (2025)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PARISE FILHO, ROBERTO - FCF ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; GARNIQUE, ANALÍ DEL MILAGRO BERNABÉ - ICB ; CARLOS, JORGE ANTONIO ELIAS GODOY - ICB ; PARDUCCI, NATÁLIA SUDAN - ICB ; WAITMAN, KAROLINE DE BARROS - FCF
- Unidades: ICB; FCF
- DOI: 10.1016/j.htct.2025.103757
- Subjects: LEUCEMIA; PRODUTOS NOVOS; FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 47, n. 2, p. 1-5 art. 103757, 2025
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
GARNIQUE, Anali Del Milagro Bernabe et al. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, v. 47, n. 2, p. 1-5 art. 103757, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.htct.2025.103757. Acesso em: 31 mar. 2026. -
APA
Garnique, A. D. M. B., Carlos, J. A. E. G., Parducci, N. S., Tavares, M. T., Waitman, K. de B., Lima, K., et al. (2025). Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy, 47( 2), 1-5 art. 103757. doi:10.1016/j.htct.2025.103757 -
NLM
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitman K de B, Lima K, Lotufo LVC, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 1-5 art. 103757.[citado 2026 mar. 31 ] Available from: https://dx.doi.org/10.1016/j.htct.2025.103757 -
Vancouver
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitman K de B, Lima K, Lotufo LVC, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase kinase inhibitor potentiates venetoclax induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 1-5 art. 103757.[citado 2026 mar. 31 ] Available from: https://dx.doi.org/10.1016/j.htct.2025.103757 - Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia
- Purine-derived Phenylhydroxamate compounds induces cell death in hematological neoplasm models
- Purine-derived phenylhydroxamate compounds reduce cell viability and modulate HDAC activity in hematological neoplasm models
- Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
- Dona Flor and her two husbands: discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment
- A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells
- Exploring the dual role of SIVA1 in cancer biology
- New kinase and HDAC hybrid inhibitors: recent advances and perspectives
- Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitors
- Design of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
